Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis-Reference-Cited by-同舟云学术

Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis

Published:2014-11 Issue: Volume:146 Page:78-86
ISSN:0014-4894
Container-title:Experimental Parasitology
language:en
Short-container-title:Experimental Parasitology

Author:

Eskandari Faeze,Talesh Ghazal Alipour,Parooie Maryam,Jaafari Mahmoud Reza,Khamesipour Ali,Saberi Zahra,Abbasi Azam,Badiee Ali

Funder

Mashhad University of Medical Sciences (MUMS)

Tehran University of Medical Sciences (TUMS)

Publisher

Elsevier BV

Subject

Immunology,General Medicine,Parasitology,Infectious Diseases

Reference66 articles.

1. The next generation of liposome delivery systems: recent experience with tumor-targeted, sterically-stabilized immunoliposomes and active-loading gradients;Abra;J. Liposome Res,2002

2. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major;Afonso;Science,1994

3. Leishmania species: models of intracellular parasitism;Alexander;J. Cell Sci,1999

4. The preparation and evaluation of reference leishmanin from Leishmania major for use in man for diagnostic and experimental purposes;Alimohammadian;Med. J. Islam. Repub. Iran,1993

5. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates;Allen;Clin. Cancer Res,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLGA nanoparticle-delivered Leishmania antigen and TLR agonists as a therapeutic vaccine against cutaneous leishmaniasis in BALB/c mice;International Immunopharmacology;2024-09

2. Emerging Trends in Lipid-Based Vaccine Delivery: A Special Focus on Developmental Strategies, Fabrication Methods, and Applications;Vaccines;2023-03-15

3. The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis;International Journal of Pharmaceutics;2023-02

4. Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview;European Journal of Pharmacology;2022-05

5. Dipeptidylcarboxypeptidase of Leishmania donovani: A potential vaccine molecule against experimental visceral leishmaniasis;Cellular Immunology;2022-05